4.6 Review

Glycoprotein VI interplay with fibrin(ogen) in thrombosis

Related references

Note: Only part of the references are listed.
Article Hematology

Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition

Philippe Billiald et al.

Summary: This study shows that glenzocimab, a humanized antibody fragment, blocks the binding of GPVI to vascular collagen and fibrin through steric hindrance and structural change. This finding is significant for the development of new antiplatelet molecules with a low bleeding risk.

BLOOD ADVANCES (2023)

Article Biochemistry & Molecular Biology

Temporal Roles of Platelet and Coagulation Pathways in Collagen- and Tissue Factor-Induced Thrombus Formation

Stefano Navarro et al.

Summary: This study utilized microfluidics technology and pharmacological intervention to acutely block and investigate key pathways of thrombus and clot formation in a short period of time, revealing the crucial roles of certain molecular pathways in the initial minutes of thrombus buildup.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Medicine, General & Internal

Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19 A Randomized Clinical Trial

Jeffrey S. Berger et al.

Summary: Adding a P2Y12 inhibitor to anticoagulant therapy did not result in improved organ support-free days in non-critically ill COVID-19 patients hospitalized for COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Medicine, General & Internal

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Peter W. Horby et al.

Summary: In patients hospitalized with COVID-19, aspirin was not associated with reductions in 28-day mortality or in the risk of progressing to invasive mechanical ventilation or death, but was associated with a small increase in the rate of being discharged alive within 28 days.

LANCET (2022)

Editorial Material Hematology

GPVI and collagen: the final word?

Alexandre Slater et al.

Summary: The authors of this study report the structure of platelet glycoprotein VI complexed with collagen-related peptides and propose the structural basis of GPVI clustering on collagen fibers.

BLOOD (2022)

Article Hematology

Structural insights into collagen binding by platelet receptor glycoprotein VI

Louris J. Feitsma et al.

Summary: Glycoprotein VI (GPVI) plays a crucial role in collagen-induced platelet activation and is essential in the development of thrombosis, heart attack, and stroke. This study reveals the crystal structures of GPVI bound to collagen peptides and identifies the binding site and essential residues for collagen binding. The study also demonstrates the binding of GPVI to collagen chains containing the sequence motif OGPOGP. These findings provide insights for the development of receptor-specific therapeutics targeting GPVI.

BLOOD (2022)

Article Medicine, General & Internal

Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial

Charlotte A. Bradbury et al.

Summary: The study results showed that among critically ill patients with COVID-19, treatment with an antiplatelet agent compared with no antiplatelet agent did not significantly improve the number of organ support-free days within 21 days. The use of antiplatelet therapy in critically ill patients with COVID-19 did not show significant benefits.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Hematology

Anti-GPVI nanobody blocks collagen- and atherosclerotic plaque-induced GPVI clustering, signaling, and thrombus formation

Natalie J. Jooss et al.

Summary: This study emphasizes the critical difference in GPVI-mediated platelet activation by plaque and collagen, highlighting the importance of GPVI clustering for downstream signaling and thrombus formation. Labeled Nb28 is a novel tool for providing mechanistic insight into this process, and the data suggest Nb2 warrants further investigation as a potential anti-thrombotic agent.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Clinical Neurology

Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Multicenter Randomized Phase II Trial

Timo Uphaus et al.

Summary: The study demonstrates that administration of Revacept 120 mg can reduce the occurrence of ischemic lesions or other adverse events in patients with symptomatic ICA stenosis.

STROKE (2022)

Article Hematology

Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19

Cedric Garcia et al.

Summary: Platelets from patients with severe COVID-19 exhibit activation, partial desensitization, and selective autophagy response to viral material.

BLOOD ADVANCES (2022)

Article Biochemistry & Molecular Biology

Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1

Ilaria De Simone et al.

Summary: Platelet and coagulation activation are reciprocal processes, and factors other than thrombin or fibrin can induce platelet activation via GPVI and PAR receptors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Hematology

Anti-GPVI Fab reveals distinct roles for GPVI signaling in the first platelet layer and subsequent layers during microfluidic clotting on collagen with or without tissue factor

Y. Zhang et al.

Summary: The collagen receptor glycoprotein VI (GPVI) plays an important role in platelet activation, but its role in later stages of clotting is not clear. By adding anti-human GPVI Fab at different time points, researchers found that GPVI has distinct effects on platelet deposition, fibrin formation, P-selectin exposure, and phosphatidylserine (PS) exposure.

THROMBOSIS RESEARCH (2022)

Article Hematology

Factor XIII is a newly identified binding partner for platelet collagen receptor GPVI-dimer-An interaction that may modulate fibrin crosslinking

Masaaki Moroi et al.

Summary: The study found that GPVI-dimer specifically binds to the A-subunit of FXIII, inhibiting the crosslinking of fibrin gamma-chains in clots catalyzed by FXIII, thus regulating clot formation.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

Article Cell Biology

The basement membrane protein nidogen-1 supports platelet adhesion and activation

Hari Hara Sudhan Lakshmanan et al.

Summary: In this study, it was demonstrated that recombinant human nidogen-1 supports platelet adhesion and activates platelets in a kinase-dependent manner downstream. Platelet adhesion to nidogen-1 was found to activate the IKK complex, while pharmacological inhibition of IKK blocked platelet spreading on nidogen. Overall, these results suggest that nidogen may play a redundant role in hemostasis by activating platelets downstream of GPVI.

PLATELETS (2021)

Article Hematology

Nonredundant Roles of Platelet Glycoprotein VI and Integrin αIIbβ3 in Fibrin-Mediated Microthrombus Formation

Gina Perrella et al.

Summary: The study revealed that fibrin fibers play a consolidating role in microthrombus formation through nonredundant signaling of platelet glycoprotein VI and integrin alpha IIb beta 3 via Syk and low-level Ca2+ rises, even in the absence of thrombin, leading to minimal thrombin generation.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Article Hematology

GPVI (Glycoprotein VI) Interaction With Fibrinogen Is Mediated by Avidity and the Fibrinogen αC-Region

Rui-Gang Xu et al.

Summary: The study demonstrates that dimeric GPVI binds to fibrinogen with higher affinity compared to the monomer, primarily through avidity effects. The interaction of GPVI with the α C-region of fibrinogen is crucial for its binding. These findings suggest that clustering of GPVI through the α C-region during fibrin polymerization may lead to downstream signaling, platelet activation, and clot growth.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Article Neurosciences

Targeting platelet glycoprotein VI attenuates progressive ischemic brain damage before recanalization during middle cerebral artery occlusion in mice

Michael Bieber et al.

Summary: Research has shown that blocking the activatory platelet receptor can delay the progression of neocortical infarction in acute ischemic stroke caused by large vessel occlusion, as well as mitigate the local vascular recruitment of neutrophils and T-cells. This experimental data supports ongoing clinical trials of blocking platelet GPVI in acute ischemic stroke.

EXPERIMENTAL NEUROLOGY (2021)

Article Biochemistry & Molecular Biology

The Proteoglycan Biglycan Modulates Platelet Adhesion and Thrombus Formation in a GPVI-Dependent Manner

Henrike Hoermann et al.

Summary: Biglycan plays a crucial role in hemostasis and thrombosis by binding and activating platelets through GPVI. Deficiency of biglycan results in reduced platelet adhesion to injured vessels and prolonged bleeding times.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Hematology

Structural characterization of a novel GPVI-nanobody complex reveals a biologically active domain-swapped GPVI dimer

Alexandre Slater et al.

Summary: The research found that the nanobody Nb2 against GPVI can effectively inhibit collagen-induced platelet aggregation, showing strong binding ability and low KD value. The binding epitope of Nb2 is located adjacent to the collagen-related peptide binding groove in the D1 domain. Additionally, a novel conformation of GPVI involving a domain swap between the D2 domains was observed.

BLOOD (2021)

Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial

Katharina Mayer et al.

Summary: The study aimed to evaluate a novel antithrombotic drug, revacept, which failed to reduce myocardial injury in patients with stable ischemic heart disease undergoing percutaneous coronary intervention. There were few bleeding events and no significant differences between treatment arms.

JAMA CARDIOLOGY (2021)

Article Hematology

Dimers of the platelet collagen receptor glycoprotein VI bind specifically to fibrin fibers during clot formation, but not to intact fibrinogen

Masaaki Moroi et al.

Summary: The study found that dimeric GPVI acts as the receptor for fibrin, with different binding affinities to noncrosslinked and crosslinked fibrin clots. Its binding kinetics are similar to those obtained for binding to fibrinogen D-fragment and D-dimer, suggesting that the GPVI-binding site on fibrin(ogen) becomes exposed after fibrin formation or cleavage. Analysis of platelets bound to fibrin clots indicates that platelet GPVI binds to fibrin fibers comprising the clot.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Letter Hematology

Differential Role of Glycoprotein VI in Mouse and Human Thrombus Progression and Stability

Emily Janus-Bell et al.

THROMBOSIS AND HAEMOSTASIS (2021)

Article Hematology

Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin

Muhammad Usman Ahmed et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Article Multidisciplinary Sciences

GPR56/ADGRG1 is a platelet collagen-responsive GPCR and hemostatic sensor of shear force

Jennifer Yeung et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Hemostasis vs. homeostasis: Platelets are essential for preserving vascular barrier function in the absence of injury or inflammation

Shuchi Gupta et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Cell Biology

Does fibrin(ogen) bind to monomeric or dimeric GPVI, or not at all?

Alexandre Slater et al.

PLATELETS (2019)

Article Cell Biology

Platelet glycoprotein VI genetic quantitative and qualitative defects

Martine Jandrot-Perrus et al.

PLATELETS (2019)

Review Clinical Neurology

Thrombo-inflammation in acute ischaemic stroke - implications for treatment

Guido Stoll et al.

NATURE REVIEWS NEUROLOGY (2019)

Review Medicine, Research & Experimental

Functional significance of the platelet immune receptors GPVI and CLEC-2

Julie Rayes et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Hematology

Fibrinogen and fibrin: An illustrated review

Marlien Pieters et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)

Article Hematology

Platelets Drive Thrombus Propagation in a Hematocrit and Glycoprotein VI-Dependent Manner in an In Vitro Venous Thrombosis Model

Marcus Lehmann et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)

Article Hematology

Immobilized fibrinogen activates human platelets through glycoprotein VI

Pierre H. Mangin et al.

HAEMATOLOGICA (2018)

Article Hematology

Immobilized fibrinogen activates human platelets through glycoprotein VI

Pierre H. Mangin et al.

HAEMATOLOGICA (2018)

Article Hematology

Proteolytic processing of platelet receptors

Elizabeth E. Gardiner

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)

Article Hematology

Fibrin and D-dimer bind to monomeric GPVI

Marie-Blanche Onselaer et al.

BLOOD ADVANCES (2017)

Article Hematology

Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury

Christina Pachel et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)

Editorial Material Hematology

Liver-mediated shedding of platelet GPVI

Michael C. Berndt et al.

BLOOD (2016)

Article Hematology

Fibrin activates GPVI in human and mouse platelets

Osama M. Alshehri et al.

BLOOD (2015)

Article Hematology

Visualization of fibrinogen αC regions and their arrangement during fibrin network formation by high-resolution AFM

A. D. Protopopova et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)

Article Multidisciplinary Sciences

A Computational Study of Stimulus Driven Epileptic Seizure Abatement

Peter Neal Taylor et al.

PLOS ONE (2014)

Article Hematology

Platelet Glycoprotein VI Dimerization, an Active Process Inducing Receptor Competence, Is an Indicator of Platelet Reactivity

Stephane Loyau et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)

Article Cell Biology

Extracellular Matrix Proteins in Hemostasis and Thrombosis

Wolfgang Bergmeier et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)

Article Pharmacology & Pharmacy

A Humanized Glycoprotein VI (GPVI) Mouse Model to Assess the Antithrombotic Efficacies of Anti-GPVI Agents

Pierre Henri Mangin et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)

Article Hematology

Comparison of two murine models of thrombosis induced by atherosclerotic plaque injury

Beatrice Hechler et al.

THROMBOSIS AND HAEMOSTASIS (2011)

Article Hematology

A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder

C. Hermans et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)

Article Hematology

Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpura

E. E. Gardiner et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)

Review Hematology

Platelet glycoprotein VI-related clinical defects

Jane F. Arthur et al.

BRITISH JOURNAL OF HAEMATOLOGY (2007)

Article Biochemistry & Molecular Biology

Ligand binding rapidly induces disulfide-dependent dimerization of glycoprotein VI on the platelet plasma membrane

Jane F. Arthur et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Hematology

Glycoprotein VI oligomerization in cell lines and platelets

O. Berlanga et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Article Hematology

Decreased thrombotic tendency in mouse models of the Bernard-Soulier syndrome

C. Strassel et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)

Review Genetics & Heredity

Bernard-Soulier syndrome (Hemorrhagiparous thrombocytic dystrophy)

Francois Lanza

ORPHANET JOURNAL OF RARE DISEASES (2006)

Article Hematology

Two-phase antithrombotic protection after anti-glycoprotein VI treatment in mice

Valerie Schulte et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)

Review Genetics & Heredity

Glanzmann thrombasthenia

Alan T. Nurden

ORPHANET JOURNAL OF RARE DISEASES (2006)

Article Biochemistry & Molecular Biology

Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI

S Penz et al.

FASEB JOURNAL (2005)

Review Hematology

The role of collagen in thrombosis and hemostasis

RW Farndale et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)

Article Hematology

Principal role of glycoprotein VI in α2β1 and αIIbβ3 activation during collagen-induced thrombus formation

C Lecut et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)

Article Immunology

A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo

S Massberg et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2003)

Article Immunology

Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice

B Nieswandt et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2001)